- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06475482
Development of a Novel Polyherbal Lip Hydrant for Improving Biophysical Barrier of the Lips
June 25, 2024 updated by: Chulalongkorn University
- The goal of this clinical trial is to evaluate the efficacy of the novel polyherbal lip hydrant on dryness, fine lines and color of the lips in 66Thai people aged between 18-40 years old. The inclusion criteria will include subjects with subjective complaint of dry lips.The main question it aims to answer is Does the novel polyherbal lip hydrant improve biophysical barrier of the lips?
- Participant will be asked to apply the lip hydrant or the petroleum gel once a day before bedtime, and refrain from using other lip products throughout the clinical trial period (28 days).
- Researchers will compare control group (Petroleum gel) with lip hydrant group to see whether biophysical barrier (wrinkles, colors, fine lines, roughness) improve or not.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bangkok, Thailand, 10330
- Faculty of Dentistry, Chulalongkorn University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- subjects with subjective complaint of dry lips;
- agree to comply with the study protocol
- agree not to apply any other products such as lipstick, lip gloss, lip conditioner to the lips other than the test product for the duration of the study
- provide a written informed consent prior to study enrollment.
Exclusion Criteria:
- Participants those having visible skin conditions which might interfere with the outcome assessment
- having a history of sensitivities to cosmetics products, or moisturizers; - having a known or suspected intolerance or hypersensitivity to herbal products or any of its ingredient
- taking medication or under the care of a doctor for one month prior to the commencement of the study, and throughout the entire test period
- having other types of cheilitis except cheilitis simplex.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Petroleum gel (Vaseline)
control group
|
Vaseline
|
|
Active Comparator: Lip hydrant
experimental group
|
lip hydrant containing peppermint oil, perilla frutescens, and Emblica fruit extract or petroleum gel.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Objective evaluation
Time Frame: 30 minutes per 1 participant
|
Objective evaluation; using
|
30 minutes per 1 participant
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Subjective evaluation
Time Frame: 5 minutes per 1 participant
|
will be assessed at day 0 (baseline), day 1 and day 28 by using a self-reported questionnaire in scale from 1-10 points for patient's dry lip score which higher score means more dry lip feeling
|
5 minutes per 1 participant
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tamura E, Ishikawa J, Yasuda Y, Yamamoto T. The efficacy of synthetic pseudo-ceramide for dry and rough lips. Int J Cosmet Sci. 2021 Apr;43(2):158-164. doi: 10.1111/ics.12677. Epub 2021 Mar 31.
- Tamura E, Yasumori H, Yamamoto T. The efficacy of a highly occlusive formulation for dry lips. Int J Cosmet Sci. 2020 Feb;42(1):46-52. doi: 10.1111/ics.12583.
- Trookman NS, Rizer RL, Ford R, Mehta R, Gotz V. Clinical assessment of a combination lip treatment to restore moisturization and fullness. J Clin Aesthet Dermatol. 2009 Dec;2(12):44-8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 3, 2024
Primary Completion (Actual)
March 27, 2024
Study Completion (Actual)
March 27, 2024
Study Registration Dates
First Submitted
February 15, 2024
First Submitted That Met QC Criteria
June 25, 2024
First Posted (Actual)
June 26, 2024
Study Record Updates
Last Update Posted (Actual)
June 26, 2024
Last Update Submitted That Met QC Criteria
June 25, 2024
Last Verified
February 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HREC-DCU2023-060
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cheilitis
-
Loyola UniversityWithdrawn
-
Hospital de Clinicas de Porto AlegreFederal University of Rio Grande do SulTerminatedActinic CheilitisBrazil
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedActinic CheilitisNorway
-
Nova Scotia Health AuthorityWithdrawn
-
Instituto Nacional de Cancer, BrazilWithdrawnActinic Cheilitis
-
Dartmouth-Hitchcock Medical CenterDUSA Pharmaceuticals, Inc.CompletedActinic CheilitisUnited States
-
Dong-A UniversityCompletedActinic CheilitisKorea, Republic of
-
Gaziosmanpasa Research and Education HospitalCompletedPostoperative Complications | Adenotonsillar Hypertrophy | Cheilitis, AngularTurkey
-
Instituto Nacional de Cancer, BrazilUnknownLeukoplakia | Erythroplakia | Actinic Cheilitis
-
Tufts Medical CenterDUSA Pharmaceuticals, Inc.CompletedActinic Cheilitis | Squamous Cell Carcinoma In-situ (SCC-is) | Squamous Cell Carcinoma (SCC) | Photodynamic Therapy (PDT) | Mohs SurgeryUnited States
Clinical Trials on Petroleum gel
-
Assiut UniversityNot yet recruiting
-
Emory UniversityLondon School of Hygiene and Tropical Medicine; Johns Hopkins University; Washington... and other collaboratorsCompletedInfant, Low Birth WeightIndia, Peru, Guatemala, Rwanda
-
University of CalgaryNot yet recruitingBreast Surgery | Surgical Wound | Wound Breakdown | Breast Reduction
-
Sashwati RoyNational Institute of Nursing Research (NINR)Active, not recruitingDiabetic Foot Ulcers | Burn Wound | Wound | Chronic Wound | Pressure Ulcers | Venous Leg Ulcers | ChronicUnited States
-
Ascension HealthTerminatedSeborrheic DermatitisUnited States
-
Columbia UniversityNational Institute of Environmental Health Sciences (NIEHS); Thrasher Research... and other collaboratorsCompletedPneumonia | Very Low Birth Weight BabyUnited States, Ghana
-
Western University of Health SciencesCompletedOnychomycosisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); KeraNetics, LLCCompletedHead and Neck Cancer | Radiation DermatitisUnited States
-
Birken AGUniversity Hospital TuebingenCompletedActinic KeratosesGermany, Greece
-
Starpharma Pty LtdCompletedBacterial VaginosisUnited States